State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR China.
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, PR China.
Biomaterials. 2015 Jun;53:160-72. doi: 10.1016/j.biomaterials.2015.02.077. Epub 2015 Mar 13.
There are several obstacles in the process of successful treatment of malignant tumors, including toxicity to normal cells, inefficiency of drug permeation and accumulation into the deep tissue of solid tumor, and multidrug resistance (MDR). In this work, we prepared docetaxel (DTX)-loaded hybrid micelles with DSPE-PEG and TPGS (TPGS/DTX-M), where TPGS serves as an effective P-gp inhibitor for overcoming MDR, and active targeting hybrid micelles (FA@TPGS/DTX-M) with targeting ligand of folate on the hybrid micelles surface offering active targeting to folate receptor-overexpressed tumor cells. A systematic comparative evaluation of these micelles on cellular internalization, sub-cellular distribution, antiproliferation, mitochondrial membrane potential, cell apoptosis and cell cycle, permeation and inhibition on 3-dimensional multicellular tumor spheroids, as well as antitumor efficacy and safety assay in vivo were well performed between sensitive KB tumors and resistant KBv tumors, and among P-gp substrate or not. We found that the roles of folate and TPGS varied due to the sensitivity of tumors and the loaded molecules in the micelles. Folate and folate receptor-mediated endocytosis played a leading role in internalization, permeation and accumulation for sensitive tumors and non-substrates of P-gp. On the contrary, TPGS played the predominant role which dramatically decreased the efflux of drugs both when the tumor is resistant and for P-gp substrate. These findings are very meaningful for guiding the design of carrier delivery system to treat tumors. The antitumor efficacy in xenograft nude mice model and safety assay showed that the TPGS/DTX-M and FA@TPGS/DTX-M significantly exhibited higher antitumor activity against resistant KBv tumors than the marketed formulation and normal micelles owing to the small size (approximately 20 nm), hydrophilic PEGylation, TPGS inhibition of P-gp function, and folate receptor-modified endocytosis, permeation and accumulation in solid tumor, as well as synergistic effects of DTX-induced cell division inhibition, growth restraint and TPGS-triggered mitochondrial apoptosis in tumor cells. In conclusion, folate-modified TPGS hybrid micelles provide a synergistic strategy for effective delivery of DTX into KBv cells and overcoming MDR.
恶性肿瘤治疗的成功存在几个障碍,包括对正常细胞的毒性、药物渗透和积累到实体瘤深部组织的效率低以及多药耐药(MDR)。在这项工作中,我们制备了载有紫杉醇(DTX)的 DSPE-PEG 和 TPGS(TPGS/ DTX-M)混合胶束,其中 TPGS 作为一种有效的 P-糖蛋白抑制剂,用于克服 MDR,并且在混合胶束表面具有叶酸靶向配体的主动靶向混合胶束(FA@TPGS/ DTX-M)为叶酸受体过表达的肿瘤细胞提供主动靶向。在敏感 KB 肿瘤和耐药 KBv 肿瘤之间,以及在 P-糖蛋白底物与非底物之间,对这些胶束在细胞内化、亚细胞分布、增殖抑制、线粒体膜电位、细胞凋亡和细胞周期、3D 多细胞肿瘤球体渗透和抑制以及体内抗肿瘤功效和安全性方面进行了系统比较评估。我们发现,叶酸和 TPGS 的作用因肿瘤的敏感性和胶束中载药分子的不同而不同。叶酸和叶酸受体介导的内吞作用在敏感肿瘤和非 P-糖蛋白底物的内化、渗透和积累中起主导作用。相反,TPGS 发挥了主要作用,当肿瘤耐药和 P-糖蛋白底物时,药物的外排显著减少。这些发现对于指导治疗肿瘤的载体传递系统的设计具有重要意义。在异种移植裸鼠模型中的抗肿瘤功效和安全性研究表明,由于 TPGS/ DTX-M 和 FA@TPGS/ DTX-M 的粒径较小(约 20nm)、亲水性 PEG 化、TPGS 抑制 P-糖蛋白功能以及叶酸受体修饰的内吞作用、渗透和在实体瘤中的积累,以及 DTX 诱导的细胞分裂抑制、生长抑制和 TPGS 触发的线粒体凋亡在肿瘤细胞中的协同作用,与市售制剂和普通胶束相比,TPGS/ DTX-M 和 FA@TPGS/ DTX-M 对耐药 KBv 肿瘤表现出更高的抗肿瘤活性。总之,叶酸修饰的 TPGS 混合胶束为有效递送至 KBv 细胞中的 DTX 提供了一种协同策略,并克服了 MDR。